Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat
- 23 July 1993
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 157 (2) , 223-226
- https://doi.org/10.1016/0304-3940(93)90742-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolismEuropean Journal of Pharmacology, 1991
- Effects of haloperidol and clozapine on preprotachykinin‐A messenger RNA, tachykinin tissue levels, release and neurokinin‐1 receptors in the striato‐nigral systemSynapse, 1990
- Comparison of the binding of radiolabelled neurokinin A and eledoisin in rat cortex synaptic membranesBritish Journal of Pharmacology, 1988
- Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonistsMolecular Brain Research, 1987
- Mismatches between neurotransmitter and receptor localizations in brain: observations and implicationsNeuroscience, 1987
- Selective agonists for substance P and neurokinin receptorsPublished by Elsevier ,1987
- Multiple tachykinin binding sites in peripheral tissues and in brainEuropean Journal of Pharmacology, 1986
- Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous systemPeptides, 1986
- Response of mesolimbic substance P systems to methamphetamine treatmentEuropean Journal of Pharmacology, 1986
- Substance K and substance P in the ventral tegmental areaNeuroscience Letters, 1985